FAC Explorer

Finding 10495 (2022-004)

Significant Deficiency
Requirement
L
Questioned Costs
-
Year
2022
Accepted
2024-01-29
Audit: 14190
Organization: Fusion Parterships, Inc. (MD)
Auditor: L Abrams & Company LLC

AI Summary

  • Answer: There are discrepancies between internal financial reports and the reports submitted to funders.
  • Trend: This issue indicates a pattern of inconsistent reporting that could affect compliance.
  • List: Follow up by reviewing internal controls and ensuring alignment between QuickBooks and funder requirements.

Finding Text

During our testing of internal controls, we identified reports are completed as identified in the grant agreement, however, there are some internal control issues where the financial reports internally (Quick Books) do not always match to the funder required submitted reports.

Corrective Action Plan

Although Fusion reviews all backup submitted to funders for reimbursement, where our process has fallen short is in the corrections to the finance reports internally to match what is submitted in real time. This will be corrected moving forward with the new finance system and additional process added by our AR staff reviewing expenses when invoices are submitted to ensure accuracy. Moving forward Fusion’s new finance system will also be able to invoice on expenses booked to grants. We anticipate this system being up and running in Q2 of 2024. Additional reviews will be added upon invoicing to ensure program staff budgets and finance recording are in sync.

Categories

Internal Control / Segregation of Duties

Other Findings in this Audit

  • 10489 2022-001
    Significant Deficiency
  • 10490 2022-001
    Significant Deficiency
  • 10491 2022-002
    Significant Deficiency
  • 10492 2022-002
    Significant Deficiency
  • 10493 2022-003
    Significant Deficiency
  • 10494 2022-003
    Significant Deficiency
  • 10496 2022-005
    Significant Deficiency
  • 10497 2022-005
    Significant Deficiency
  • 586931 2022-001
    Significant Deficiency
  • 586932 2022-001
    Significant Deficiency
  • 586933 2022-002
    Significant Deficiency
  • 586934 2022-002
    Significant Deficiency
  • 586935 2022-003
    Significant Deficiency
  • 586936 2022-003
    Significant Deficiency
  • 586937 2022-004
    Significant Deficiency
  • 586938 2022-005
    Significant Deficiency
  • 586939 2022-005
    Significant Deficiency

Programs in Audit

ALN Program Name Expenditures
93.788 Opioid Str $530,796
21.027 Coronavirus State and Local Fiscal Recovery Funds $428,403
00.000 Parole Hearing and Reentry Preparation $209,967
93.307 Minority Health and Health Disparities Research $130,488
00.000 Community Engagement Research Alliance $126,938
00.000 Collective for Antiracist Child and Family Systems $50,436
16.034 Coronavirus Emergency Supplemental Funding Program $577